## Understanding Ideal Screening Test Characteristics **Key Point:** Positive predictive value (PPV) is NOT an intrinsic property of a test — it varies directly with disease prevalence in the population being screened. ### Why PPV Cannot Be Universally High Positive predictive value is defined as: $$PPV = \frac{TP}{TP+FP}$$ Where TP = true positives and FP = false positives. In a **low-prevalence population**, even a test with excellent sensitivity and specificity will have a **low PPV** because false positives outnumber true positives. This is a fundamental statistical property, not a flaw in test design. **Example:** A screening test with 95% sensitivity and 95% specificity applied to a disease with 1% prevalence will have a PPV of only ~16%, meaning 84% of positive results are false positives. ### Characteristics of an Ideal Screening Test | Characteristic | Why Important | |---|---| | High sensitivity | Minimizes false negatives; catches disease early | | High specificity | Minimizes false positives; reduces unnecessary workup | | Simple and safe | Encourages participation and compliance | | Acceptable to population | Increases uptake and screening coverage | | Cost-effective | Justifies resource allocation | | Detects disease in early/treatable stage | Improves prognosis | | Reliable and reproducible | Ensures consistent results | **High-Yield:** The statement "high PPV in all populations" is a **trap answer** because PPV depends on prevalence — it is NOT an intrinsic test property. **Clinical Pearl:** When screening for rare diseases, even highly specific tests will have poor PPV. This is why screening programs target conditions with moderate-to-high prevalence in the target population.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.